New WHO guidelines on drug-resistant TB treatment recommend rapid roll-out of the novel BPaLM/BPaL regimen that has the potential to significantly increase cure rates due to its high effectiveness, offer more extensive access because of its lower cost, and improve patients' quality of life, as it is an all-oral treatment that is considerably shorter than traditional regimens.
“On World TB Day, WHO is pressing for firm political commitment at the highest level, strong multisectoral collaboration including beyond health, and an effective accountability system.
15055
我们需要所有人,包括个人、社区、社会、捐助者和政府,都为终止结核病尽自己的一份力量。
We need everyone--individuals, communities, societies, donors and governments--to do their part to end TB.